A practical approach is to divide each region into quadrants or zones and systematically rotate injections, ensuring at least 1 cm distance between consecutive injection sites
Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, said John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDAs Center for Drug Evaluation and Research
Rest and monitor Theres a high chance youll experience heightened nausea and GI discomfort
Furthermore, Foundayo (orforglipron) serves as an innovative oral GLP-1 alternative, granting flexibility with its anytime administration unbound by food and water
When transitioning between them , matching the appropriate dose level prevents both under-treatment and excessive side effects during the changeover period
This medication is truly unique because it acts as a dual agonist, meaning it targets two different hormone receptors in your body: Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP)